|
gptkbp:instance_of
|
gptkb:virus
|
|
gptkbp:cause
|
gptkb:virus
|
|
gptkbp:chronic_infection_management
|
regular monitoring
|
|
gptkbp:community_health
|
yes
|
|
gptkbp:condition
|
gptkb:hepatocellular_carcinoma
|
|
gptkbp:diagnosis
|
blood test
|
|
gptkbp:discovered_by
|
gptkb:1967
|
|
gptkbp:diseases
|
gptkb:HCV
gptkb:HIV
possible
HDV
10% to 15% of adults
90% of infants
|
|
gptkbp:duration
|
long-term
|
|
gptkbp:epidemiology
|
endemic in Africa
endemic in Asia
endemic in Eastern Europe
endemic in the Middle East
endemic in the Pacific Islands
|
|
gptkbp:family
|
gptkb:Hepadnaviridae
|
|
gptkbp:genus
|
gptkb:Orthohepadnavirus
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
hepatitis B virus
|
|
gptkbp:incubation_period
|
30 to 180 days
|
|
gptkbp:is_vulnerable_to
|
yes
|
|
gptkbp:liver_biopsy
|
used for assessment
|
|
gptkbp:liver_disease
|
liver cancer
cirrhosis
|
|
gptkbp:liver_function_test
|
used for monitoring
|
|
gptkbp:liver_transplant
|
possible treatment option
|
|
gptkbp:prevalence
|
high
|
|
gptkbp:prevention
|
vaccination
|
|
gptkbp:research_focus
|
immune response
vaccine development
viral replication
antiviral therapy
|
|
gptkbp:risk_factor
|
sharing needles
unprotected sex
exposure to infected blood
mother with hepatitis B
|
|
gptkbp:scientific_classification
|
gptkb:Group_1_carcinogen
|
|
gptkbp:seed_dispersal
|
partially double-stranded DNA
|
|
gptkbp:serological_markers
|
HBs Ag
anti-HBc
anti-HBs
|
|
gptkbp:symptoms
|
fatigue
nausea
abdominal pain
jaundice
loss of appetite
|
|
gptkbp:transmission
|
gptkb:blood
sexual contact
mother to child
|
|
gptkbp:treatment
|
gptkb:immunotherapy
viral suppression
|
|
gptkbp:bfsParent
|
gptkb:virus
|
|
gptkbp:bfsLayer
|
4
|